These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23456436)

  • 1. In vitro and in vivo evaluation of amorphous solid dispersions generated by different bench-scale processes, using griseofulvin as a model compound.
    Chiang PC; Cui Y; Ran Y; Lubach J; Chou KJ; Bao L; Jia W; La H; Hau J; Sambrone A; Qin A; Deng Y; Wong H
    AAPS J; 2013 Apr; 15(2):608-17. PubMed ID: 23456436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
    Mahmah O; Tabbakh R; Kelly A; Paradkar A
    J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.
    Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F
    Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of griseofulvin binary and ternary solid dispersions with HPMCAS.
    Al-Obaidi H; Buckton G
    AAPS PharmSciTech; 2009; 10(4):1172-7. PubMed ID: 19842041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.
    Al-Obaidi H; Lawrence MJ; Al-Saden N; Ke P
    Int J Pharm; 2013 Feb; 443(1-2):95-102. PubMed ID: 23299082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane.
    Dahan A; Beig A; Ioffe-Dahan V; Agbaria R; Miller JM
    AAPS J; 2013 Apr; 15(2):347-53. PubMed ID: 23242514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions.
    Al-Obaidi H; Lawrence MJ; Buckton G
    J Pharm Pharmacol; 2016 Nov; 68(11):1373-1383. PubMed ID: 27696396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of high dispersion stable nanocrystal formulation of poorly water-soluble compounds by using povacoat.
    Yuminoki K; Seko F; Horii S; Takeuchi H; Teramoto K; Nakada Y; Hashimoto N
    J Pharm Sci; 2014 Nov; 103(11):3772-3781. PubMed ID: 25209659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of drug load and polymer by using a 96-well plate vacuum dry system for amorphous solid dispersion drug delivery.
    Chiang PC; Ran Y; Chou KJ; Cui Y; Sambrone A; Chan C; Hart R
    AAPS PharmSciTech; 2012 Jun; 13(2):713-22. PubMed ID: 22562615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.
    Zecevic DE; Meier R; Daniels R; Wagner KG
    Eur J Pharm Biopharm; 2014 Jul; 87(2):264-70. PubMed ID: 24768770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral bioavailability enhancement of β-lapachone, a poorly soluble fast crystallizer, by cocrystal, amorphous solid dispersion, and crystalline solid dispersion.
    Liu C; Liu Z; Chen Y; Chen Z; Chen H; Pui Y; Qian F
    Eur J Pharm Biopharm; 2018 Mar; 124():73-81. PubMed ID: 29305142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.
    Onoue S; Kojo Y; Aoki Y; Kawabata Y; Yamauchi Y; Yamada S
    Drug Metab Pharmacokinet; 2012; 27(4):379-87. PubMed ID: 22240843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
    Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
    Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions.
    Li N; Cape JL; Mankani BR; Zemlyanov DY; Shepard KB; Morgen MM; Taylor LS
    Mol Pharm; 2020 Oct; 17(10):4004-4017. PubMed ID: 32931293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Method of Preparation of Amorphous Solid Dispersions on Mechanical Properties: Comparison of Coprecipitation and Spray Drying.
    Hou HH; Rajesh A; Pandya KM; Lubach JW; Muliadi A; Yost E; Jia W; Nagapudi K
    J Pharm Sci; 2019 Feb; 108(2):870-879. PubMed ID: 30244013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amorphous solid dispersions of darunavir: Comparison between spray drying and electrospraying.
    Smeets A; Koekoekx R; Clasen C; Van den Mooter G
    Eur J Pharm Biopharm; 2018 Sep; 130():96-107. PubMed ID: 29928980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
    Chavan RB; Lodagekar A; Yadav B; Shastri NR
    Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Simultaneous Differential Scanning Calorimetry-X-ray Diffraction Study of Olanzapine Crystallization from Amorphous Solid Dispersions.
    Askin S; Gonçalves AD; Zhao M; Williams GR; Gaisford S; Craig DQM
    Mol Pharm; 2020 Nov; 17(11):4364-4374. PubMed ID: 33074007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated stability modeling of recrystallization from amorphous solid Dispersions: A Griseofulvin/HPMC-AS case study.
    Leon AS; Waterman KC; Wang G; Wang L; Cai T; Zhang X
    Int J Pharm; 2024 May; 657():124189. PubMed ID: 38701906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamic Modeling of Solvent-Impact on Phase Separation in Amorphous Solid Dispersions during Drying.
    Dohrn S; Reimer P; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Mol Pharm; 2020 Jul; 17(7):2721-2733. PubMed ID: 32463685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.